Design, synthesis, and structure-activity relationships of 1,3,4-oxadiazol-2(3H)-ones as novel FAAH inhibitors

MedChemComm

Volumn 2, Issue 9, 2011, Pages 889-894

  Kiss, László E ^a   Ferreira, Humberto S ^a   Beliaev, Alexandre ^a   Torrão, Leonel ^a   Bonifácio, Maria João ^a   Learmonth, David A ^a  

^a DEPARTMENT OF RESEARCH AND DEVELOPMENT   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,4 OXADIAZOL 2(3H) ONE DERIVATIVE; 3 (HYDROXYPHENYL) 5 PHENOXY 1,3,4 OXADIAZOL 2(3H) ONE DERIVATIVE; 5 PHENOXY 3 PHENYL 1,3,4 OXADIAZOL 2(3H) ONE DERIVATIVE; CATECHOL DERIVATIVE; FATTY ACID AMIDASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

EID: 80052352965     PISSN: 20402503     EISSN: 20402511     Source Type: Journal    
DOI: 10.1039/c1md00136a     Document Type: Article

References (19)

1. S. Busch J. Prakt. Chem. 1899 60 239
2. H. Busch Chem. Ber. 1901 34 2332
3. R. Boesch (Rhone-Poulenc Industries), GB Patent 1518042, 1976
4. G. Bonse, N. Müller and A. Harder (Bayer AG), European Patent EP0419918A2 1990
5. K. Schoenafinger, S. Petry, G. Mueller and K.-H. Baringhaus (Aventis Pharma Deutschland GmbH), US Patent 6369088B2, 2002
6. K. Schoenafinger, S. Petry, G. Mueller, A. Bauer and H. O. Heuer (Aventis Pharmaceuticals Inc), US Patent 0236288A1, 2003
7. K. Schoenafinger, E. Defossa, D. Kadereit, E. Von Roedern, T. Klabunde, H.-J. Burger, A. Herling and K.-U. Wendt (Sanofi-Aventis Deutschland GmbH), US Patent 7138414B2, 2006
8. M. K. McKinney B. F. Cravatt Annu. Rev. Biochem. 2005 74 411
9. B. F. Cravatt D. K. Giang S. P. Mayfield D. L. Boger R. A. Lerner N. B. Gilula Nature 1996 384 83
10. B. F. Cravatt A. H. Lichtman Curr. Opin. Chem. Biol. 2003 7 469
11. H. Deng Expert Opin. Drug Discovery 2010 5 961
12. D. A. Learmonth, L. E. Kiss, A. Beliaev, H. Ferreira and P. Soares da Silva (BIAL-Portela & Companhia S.A.), PCT Int. Appl. WO2009084970A1, 2009
13. A. Minkkilä J. R. Savinainen H. Käsnänen H. Xhaard T. Nevalainen J. T. Laitinen A. Poso J. Leppänen S. M. Saario Chem. Med. Chem. 2009 4 1253
14. J. P. Demers (Ortho Pharmaceuticals Co.) US Patent 4864032, 1989
15. F. Strain W. E. Bissinger W. R. Dial H. Rudoff B. J. DeWitt H. C. Stevens J. H. Langstone J. Am. Chem. Soc. 1950 72 1254
16. J. Huang D. F. Bushey M. D. Graves J. Heterocycl. Chem. 1987 24 1
17. S. Holt F. Comelli B. Costa C. J. Fowler Br. J. Pharmacol. 2005 146 467
18. L. Boldrup S. J. Wilson A. J. Barbier C. J. Fowler J. Biochem. Biophys. Methods 2004 62 171
19. M. Steffens A. Schulze-Bonhage R. Surges T. J. Feuerstein Neurosci. Lett. 2005 385 13